UniProt ID | SMCA4_HUMAN | |
---|---|---|
UniProt AC | P51532 | |
Protein Name | Transcription activator BRG1 | |
Gene Name | SMARCA4 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1647 | |
Subcellular Localization | Nucleus . Colocalizes with long non-coding RNA Evf2 in nuclear RNA clouds. | |
Protein Description | Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating the calcium-dependent release of a repressor complex and the recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by SMARCA4-dependent recruitment of a phospho-RB1-HDAC repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves the release of HDAC1 and recruitment of CREBBP. Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and the neuron-specific chromatin remodeling complex (nBAF complex). During neural development, a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth. SMARCA4/BAF190A may promote neural stem cell self-renewal/proliferation by enhancing Notch-dependent proliferative signals, while concurrently making the neural stem cell insensitive to SHH-dependent differentiating cues (By similarity). Acts as a corepressor of ZEB1 to regulate E-cadherin transcription and is required for induction of epithelial-mesenchymal transition (EMT) by ZEB1. Binds via DLX1 to enhancers located in the intergenic region between DLX5 and DLX6 and this binding is stabilized by the long non-coding RNA (lncRNA) Evf2 (By similarity). Binds to RNA in a promiscuous manner (By similarity). Binding to RNAs including lncRNA Evf2 leads to inhibition of SMARCA4 ATPase and chromatin remodeling activities (By similarity).. | |
Protein Sequence | MSTPDPPLGGTPRPGPSPGPGPSPGAMLGPSPGPSPGSAHSMMGPSPGPPSAGHPIPTQGPGGYPQDNMHQMHKPMESMHEKGMSDDPRYNQMKGMGMRSGGHAGMGPPPSPMDQHSQGYPSPLGGSEHASSPVPASGPSSGPQMSSGPGGAPLDGADPQALGQQNRGPTPFNQNQLHQLRAQIMAYKMLARGQPLPDHLQMAVQGKRPMPGMQQQMPTLPPPSVSATGPGPGPGPGPGPGPGPAPPNYSRPHGMGGPNMPPPGPSGVPPGMPGQPPGGPPKPWPEGPMANAAAPTSTPQKLIPPQPTGRPSPAPPAVPPAASPVMPPQTQSPGQPAQPAPMVPLHQKQSRITPIQKPRGLDPVEILQEREYRLQARIAHRIQELENLPGSLAGDLRTKATIELKALRLLNFQRQLRQEVVVCMRRDTALETALNAKAYKRSKRQSLREARITEKLEKQQKIEQERKRRQKHQEYLNSILQHAKDFKEYHRSVTGKIQKLTKAVATYHANTEREQKKENERIEKERMRRLMAEDEEGYRKLIDQKKDKRLAYLLQQTDEYVANLTELVRQHKAAQVAKEKKKKKKKKKAENAEGQTPAIGPDGEPLDETSQMSDLPVKVIHVESGKILTGTDAPKAGQLEAWLEMNPGYEVAPRSDSEESGSEEEEEEEEEEQPQAAQPPTLPVEEKKKIPDPDSDDVSEVDARHIIENAKQDVDDEYGVSQALARGLQSYYAVAHAVTERVDKQSALMVNGVLKQYQIKGLEWLVSLYNNNLNGILADEMGLGKTIQTIALITYLMEHKRINGPFLIIVPLSTLSNWAYEFDKWAPSVVKVSYKGSPAARRAFVPQLRSGKFNVLLTTYEYIIKDKHILAKIRWKYMIVDEGHRMKNHHCKLTQVLNTHYVAPRRLLLTGTPLQNKLPELWALLNFLLPTIFKSCSTFEQWFNAPFAMTGEKVDLNEEETILIIRRLHKVLRPFLLRRLKKEVEAQLPEKVEYVIKCDMSALQRVLYRHMQAKGVLLTDGSEKDKKGKGGTKTLMNTIMQLRKICNHPYMFQHIEESFSEHLGFTGGIVQGLDLYRASGKFELLDRILPKLRATNHKVLLFCQMTSLMTIMEDYFAYRGFKYLRLDGTTKAEDRGMLLKTFNEPGSEYFIFLLSTRAGGLGLNLQSADTVIIFDSDWNPHQDLQAQDRAHRIGQQNEVRVLRLCTVNSVEEKILAAAKYKLNVDQKVIQAGMFDQKSSSHERRAFLQAILEHEEQDESRHCSTGSGSASFAHTAPPPAGVNPDLEEPPLKEEDEVPDDETVNQMIARHEEEFDLFMRMDLDRRREEARNPKRKPRLMEEDELPSWIIKDDAEVERLTCEEEEEKMFGRGSRHRKEVDYSDSLTEKQWLKAIEEGTLEEIEEEVRQKKSSRKRKRDSDAGSSTPTTSTRSRDKDDESKKQKKRGRPPAEKLSPNPPNLTKKMKKIVDAVIKYKDSSSGRQLSEVFIQLPSRKELPEYYELIRKPVDFKKIKERIRNHKYRSLNDLEKDVMLLCQNAQTFNLEGSLIYEDSIVLQSVFTSVRQKIEKEDDSEGEESEEEEEGEEEGSESESRSVKVKIKLGRKEKAQDRLKGGRRRPSRGSRAKPVVSDDDSEEEQEEDRSGSGSEED | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSTPDPPLG ------CCCCCCCCC | 61.01 | 23401153 | |
3 | Phosphorylation | -----MSTPDPPLGG -----CCCCCCCCCC | 43.50 | 29255136 | |
11 | Phosphorylation | PDPPLGGTPRPGPSP CCCCCCCCCCCCCCC | 17.83 | 25159151 | |
17 | Phosphorylation | GTPRPGPSPGPGPSP CCCCCCCCCCCCCCC | 48.69 | 26074081 | |
23 | Phosphorylation | PSPGPGPSPGAMLGP CCCCCCCCCCCCCCC | 41.71 | 26074081 | |
31 | Phosphorylation | PGAMLGPSPGPSPGS CCCCCCCCCCCCCCC | 40.46 | 26074081 | |
35 | Phosphorylation | LGPSPGPSPGSAHSM CCCCCCCCCCCCCCC | 48.05 | 26074081 | |
38 | Phosphorylation | SPGPSPGSAHSMMGP CCCCCCCCCCCCCCC | 26.62 | 26074081 | |
41 | Phosphorylation | PSPGSAHSMMGPSPG CCCCCCCCCCCCCCC | 15.35 | 26074081 | |
90 | Phosphorylation | GMSDDPRYNQMKGMG CCCCCCCHHHHCCCC | 18.35 | 26074081 | |
94 | Acetylation | DPRYNQMKGMGMRSG CCCHHHHCCCCCCCC | 35.66 | 25953088 | |
100 | Phosphorylation | MKGMGMRSGGHAGMG HCCCCCCCCCCCCCC | 39.99 | 26074081 | |
111 | Phosphorylation | AGMGPPPSPMDQHSQ CCCCCCCCCCCCCCC | 38.33 | 26074081 | |
117 | Phosphorylation | PSPMDQHSQGYPSPL CCCCCCCCCCCCCCC | 21.48 | 26074081 | |
120 | Phosphorylation | MDQHSQGYPSPLGGS CCCCCCCCCCCCCCC | 7.90 | 26074081 | |
122 | Phosphorylation | QHSQGYPSPLGGSEH CCCCCCCCCCCCCCC | 25.03 | 26074081 | |
127 | Phosphorylation | YPSPLGGSEHASSPV CCCCCCCCCCCCCCC | 25.14 | 26074081 | |
131 | Phosphorylation | LGGSEHASSPVPASG CCCCCCCCCCCCCCC | 36.76 | 26074081 | |
132 | Phosphorylation | GGSEHASSPVPASGP CCCCCCCCCCCCCCC | 30.60 | 26074081 | |
137 | Phosphorylation | ASSPVPASGPSSGPQ CCCCCCCCCCCCCCC | 45.20 | 26074081 | |
140 | Phosphorylation | PVPASGPSSGPQMSS CCCCCCCCCCCCCCC | 51.99 | 26074081 | |
141 | Phosphorylation | VPASGPSSGPQMSSG CCCCCCCCCCCCCCC | 58.59 | 26074081 | |
146 | Phosphorylation | PSSGPQMSSGPGGAP CCCCCCCCCCCCCCC | 27.22 | 26074081 | |
147 | Phosphorylation | SSGPQMSSGPGGAPL CCCCCCCCCCCCCCC | 43.60 | 26074081 | |
170 | Phosphorylation | GQQNRGPTPFNQNQL CCCCCCCCCCCHHHH | 43.25 | 28555341 | |
181 | Methylation | QNQLHQLRAQIMAYK HHHHHHHHHHHHHHH | 20.20 | 30761079 | |
188 | Acetylation | RAQIMAYKMLARGQP HHHHHHHHHHHCCCC | 20.21 | 19608861 | |
192 | Methylation | MAYKMLARGQPLPDH HHHHHHHCCCCCCHH | 40.08 | 115917181 | |
207 | Acetylation | LQMAVQGKRPMPGMQ HHHHHCCCCCCCCHH | 35.92 | 25953088 | |
207 | Ubiquitination | LQMAVQGKRPMPGMQ HHHHHCCCCCCCCHH | 35.92 | - | |
296 | Phosphorylation | MANAAAPTSTPQKLI CCCCCCCCCCCCCCC | 40.27 | 25627689 | |
297 | Phosphorylation | ANAAAPTSTPQKLIP CCCCCCCCCCCCCCC | 36.71 | 25627689 | |
298 | Phosphorylation | NAAAPTSTPQKLIPP CCCCCCCCCCCCCCC | 32.01 | 25159151 | |
308 | Phosphorylation | KLIPPQPTGRPSPAP CCCCCCCCCCCCCCC | 40.34 | 28348404 | |
312 | Phosphorylation | PQPTGRPSPAPPAVP CCCCCCCCCCCCCCC | 32.12 | 29449344 | |
323 | Phosphorylation | PAVPPAASPVMPPQT CCCCCCCCCCCCCCC | 21.82 | 25850435 | |
330 | Phosphorylation | SPVMPPQTQSPGQPA CCCCCCCCCCCCCCC | 36.47 | 25850435 | |
332 | Phosphorylation | VMPPQTQSPGQPAQP CCCCCCCCCCCCCCC | 34.09 | 25850435 | |
353 | Phosphorylation | HQKQSRITPIQKPRG CCCCCCCCCCCCCCC | 17.15 | 25159151 | |
357 | Acetylation | SRITPIQKPRGLDPV CCCCCCCCCCCCCHH | 37.08 | 25953088 | |
357 | Ubiquitination | SRITPIQKPRGLDPV CCCCCCCCCCCCCHH | 37.08 | - | |
391 | Phosphorylation | ELENLPGSLAGDLRT HHHCCCCCCCCCCCC | 17.07 | 20068231 | |
399 | Ubiquitination | LAGDLRTKATIELKA CCCCCCCCHHHHHHH | 36.78 | 21890473 | |
399 | Ubiquitination | LAGDLRTKATIELKA CCCCCCCCHHHHHHH | 36.78 | 21890473 | |
399 | Ubiquitination | LAGDLRTKATIELKA CCCCCCCCHHHHHHH | 36.78 | 21890473 | |
399 | Ubiquitination | LAGDLRTKATIELKA CCCCCCCCHHHHHHH | 36.78 | 21890473 | |
399 | 2-Hydroxyisobutyrylation | LAGDLRTKATIELKA CCCCCCCCHHHHHHH | 36.78 | - | |
399 | Ubiquitination | LAGDLRTKATIELKA CCCCCCCCHHHHHHH | 36.78 | 21890473 | |
405 | Ubiquitination | TKATIELKALRLLNF CCHHHHHHHHHHHHH | 32.36 | 21890473 | |
405 | Ubiquitination | TKATIELKALRLLNF CCHHHHHHHHHHHHH | 32.36 | 21890473 | |
405 | Ubiquitination | TKATIELKALRLLNF CCHHHHHHHHHHHHH | 32.36 | 21890473 | |
405 | Ubiquitination | TKATIELKALRLLNF CCHHHHHHHHHHHHH | 32.36 | 21890473 | |
405 | Ubiquitination | TKATIELKALRLLNF CCHHHHHHHHHHHHH | 32.36 | 21890473 | |
428 | Phosphorylation | VVCMRRDTALETALN HHHCCCHHHHHHHHH | 31.19 | 28555341 | |
437 | Ubiquitination | LETALNAKAYKRSKR HHHHHHHHHHHHHHH | 51.69 | 21890473 | |
437 | Ubiquitination | LETALNAKAYKRSKR HHHHHHHHHHHHHHH | 51.69 | 21890473 | |
437 | Ubiquitination | LETALNAKAYKRSKR HHHHHHHHHHHHHHH | 51.69 | 21890473 | |
437 | Ubiquitination | LETALNAKAYKRSKR HHHHHHHHHHHHHHH | 51.69 | 21890473 | |
437 | Methylation | LETALNAKAYKRSKR HHHHHHHHHHHHHHH | 51.69 | 30795557 | |
437 | Ubiquitination | LETALNAKAYKRSKR HHHHHHHHHHHHHHH | 51.69 | 21890473 | |
446 | Phosphorylation | YKRSKRQSLREARIT HHHHHHHHHHHHHHH | 33.17 | 26074081 | |
453 | Phosphorylation | SLREARITEKLEKQQ HHHHHHHHHHHHHHH | 22.86 | 24702127 | |
455 | Acetylation | REARITEKLEKQQKI HHHHHHHHHHHHHHH | 53.98 | 23749302 | |
455 | Ubiquitination | REARITEKLEKQQKI HHHHHHHHHHHHHHH | 53.98 | - | |
458 | Ubiquitination | RITEKLEKQQKIEQE HHHHHHHHHHHHHHH | 69.35 | - | |
461 | Acetylation | EKLEKQQKIEQERKR HHHHHHHHHHHHHHH | 45.80 | 30592461 | |
471 | Ubiquitination | QERKRRQKHQEYLNS HHHHHHHHHHHHHHH | 45.50 | 21890473 | |
471 | Ubiquitination | QERKRRQKHQEYLNS HHHHHHHHHHHHHHH | 45.50 | 21890473 | |
471 | Ubiquitination | QERKRRQKHQEYLNS HHHHHHHHHHHHHHH | 45.50 | 21890473 | |
471 | Ubiquitination | QERKRRQKHQEYLNS HHHHHHHHHHHHHHH | 45.50 | 21890473 | |
471 | Ubiquitination | QERKRRQKHQEYLNS HHHHHHHHHHHHHHH | 45.50 | 21890473 | |
487 | Ubiquitination | LQHAKDFKEYHRSVT HHHHHHHHHHHHHHH | 68.45 | - | |
496 | 2-Hydroxyisobutyrylation | YHRSVTGKIQKLTKA HHHHHHHHHHHHHHH | 32.38 | - | |
496 | Acetylation | YHRSVTGKIQKLTKA HHHHHHHHHHHHHHH | 32.38 | 25953088 | |
496 | Ubiquitination | YHRSVTGKIQKLTKA HHHHHHHHHHHHHHH | 32.38 | - | |
502 | Acetylation | GKIQKLTKAVATYHA HHHHHHHHHHHHHHH | 51.83 | 26051181 | |
502 | Ubiquitination | GKIQKLTKAVATYHA HHHHHHHHHHHHHHH | 51.83 | - | |
529 | Methylation | IEKERMRRLMAEDEE HHHHHHHHHHHHCHH | 21.33 | - | |
538 | Phosphorylation | MAEDEEGYRKLIDQK HHHCHHHHHHHHHHH | 14.09 | 21406692 | |
588 | Acetylation | KKKKKKKKAENAEGQ HHHHHHHHHHCCCCC | 70.57 | 26051181 | |
596 | Phosphorylation | AENAEGQTPAIGPDG HHCCCCCCCCCCCCC | 26.08 | 23927012 | |
609 | Phosphorylation | DGEPLDETSQMSDLP CCCCCCCCCCCCCCC | 24.75 | 29255136 | |
610 | Phosphorylation | GEPLDETSQMSDLPV CCCCCCCCCCCCCCE | 23.10 | 29255136 | |
613 | Phosphorylation | LDETSQMSDLPVKVI CCCCCCCCCCCEEEE | 28.49 | 29255136 | |
618 | Acetylation | QMSDLPVKVIHVESG CCCCCCEEEEEEECC | 33.27 | 26051181 | |
624 | Phosphorylation | VKVIHVESGKILTGT EEEEEEECCCEEECC | 44.27 | 23312004 | |
626 | Ubiquitination | VIHVESGKILTGTDA EEEEECCCEEECCCC | 43.77 | 21890473 | |
626 | Ubiquitination | VIHVESGKILTGTDA EEEEECCCEEECCCC | 43.77 | 21890473 | |
626 | Ubiquitination | VIHVESGKILTGTDA EEEEECCCEEECCCC | 43.77 | 21890473 | |
626 | Ubiquitination | VIHVESGKILTGTDA EEEEECCCEEECCCC | 43.77 | 21890473 | |
626 | Acetylation | VIHVESGKILTGTDA EEEEECCCEEECCCC | 43.77 | 23954790 | |
626 | Ubiquitination | VIHVESGKILTGTDA EEEEECCCEEECCCC | 43.77 | 21890473 | |
649 | Phosphorylation | WLEMNPGYEVAPRSD HHHCCCCCCCCCCCC | 14.42 | 17081983 | |
655 | Phosphorylation | GYEVAPRSDSEESGS CCCCCCCCCCCCCCC | 44.42 | 28985074 | |
657 | Phosphorylation | EVAPRSDSEESGSEE CCCCCCCCCCCCCHH | 44.50 | 22817900 | |
660 | Phosphorylation | PRSDSEESGSEEEEE CCCCCCCCCCHHHHH | 43.50 | 28985074 | |
662 | Phosphorylation | SDSEESGSEEEEEEE CCCCCCCCHHHHHHH | 51.63 | 28985074 | |
681 | Phosphorylation | PQAAQPPTLPVEEKK CCCCCCCCCCHHHHC | 50.83 | 24144214 | |
689 | Acetylation | LPVEEKKKIPDPDSD CCHHHHCCCCCCCCC | 71.22 | 26051181 | |
689 | Ubiquitination | LPVEEKKKIPDPDSD CCHHHHCCCCCCCCC | 71.22 | - | |
695 | Phosphorylation | KKIPDPDSDDVSEVD CCCCCCCCCCCCHHH | 40.89 | 29255136 | |
699 | Phosphorylation | DPDSDDVSEVDARHI CCCCCCCCHHHHHHH | 38.61 | 29255136 | |
711 | Acetylation | RHIIENAKQDVDDEY HHHHHHHHHCCCCCC | 59.62 | 26051181 | |
711 | Ubiquitination | RHIIENAKQDVDDEY HHHHHHHHHCCCCCC | 59.62 | 21890473 | |
718 | Phosphorylation | KQDVDDEYGVSQALA HHCCCCCCHHHHHHH | 29.80 | - | |
721 | Phosphorylation | VDDEYGVSQALARGL CCCCCHHHHHHHHHH | 12.84 | 17525332 | |
730 | Phosphorylation | ALARGLQSYYAVAHA HHHHHHHHHHHHHHH | 25.75 | 28796482 | |
731 | Phosphorylation | LARGLQSYYAVAHAV HHHHHHHHHHHHHHH | 5.18 | 28796482 | |
732 | Phosphorylation | ARGLQSYYAVAHAVT HHHHHHHHHHHHHHH | 10.39 | 28796482 | |
746 | Phosphorylation | TERVDKQSALMVNGV HHCCCHHHHHHHCCE | 29.16 | 22210691 | |
767 | Phosphorylation | KGLEWLVSLYNNNLN CCHHHHHHHHHCCCC | 23.98 | 24248375 | |
769 | Phosphorylation | LEWLVSLYNNNLNGI HHHHHHHHHCCCCCH | 14.34 | 24248375 | |
786 | Phosphorylation | DEMGLGKTIQTIALI HHCCCCHHHHHHHHH | 19.27 | 21406692 | |
789 | Phosphorylation | GLGKTIQTIALITYL CCCHHHHHHHHHHHH | 12.36 | 21406692 | |
794 | Phosphorylation | IQTIALITYLMEHKR HHHHHHHHHHHHCCC | 16.08 | 21406692 | |
795 | Phosphorylation | QTIALITYLMEHKRI HHHHHHHHHHHCCCC | 9.32 | 21406692 | |
831 | Ubiquitination | KWAPSVVKVSYKGSP CCCCCEEEEEECCCH | 24.25 | - | |
833 | Phosphorylation | APSVVKVSYKGSPAA CCCEEEEEECCCHHH | 18.53 | 20860994 | |
834 | Phosphorylation | PSVVKVSYKGSPAAR CCEEEEEECCCHHHH | 23.50 | 20860994 | |
835 | Ubiquitination | SVVKVSYKGSPAARR CEEEEEECCCHHHHH | 45.46 | - | |
837 | Phosphorylation | VKVSYKGSPAARRAF EEEEECCCHHHHHHH | 13.76 | 30624053 | |
850 | Phosphorylation | AFVPQLRSGKFNVLL HHHHHHHCCCCCEEE | 55.73 | 29083192 | |
858 | Phosphorylation | GKFNVLLTTYEYIIK CCCCEEEEEHHHHHC | 24.15 | 25954137 | |
859 | Phosphorylation | KFNVLLTTYEYIIKD CCCEEEEEHHHHHCC | 17.83 | 24719451 | |
860 | Phosphorylation | FNVLLTTYEYIIKDK CCEEEEEHHHHHCCC | 11.08 | 24719451 | |
862 | Phosphorylation | VLLTTYEYIIKDKHI EEEEEHHHHHCCCHH | 9.49 | 25954137 | |
872 | Ubiquitination | KDKHILAKIRWKYMI CCCHHHHEEEEEEEE | 29.38 | - | |
991 | Acetylation | VEAQLPEKVEYVIKC HHHHCCCCCEEEHHC | 38.13 | 26051181 | |
991 | Ubiquitination | VEAQLPEKVEYVIKC HHHHCCCCCEEEHHC | 38.13 | - | |
997 | Acetylation | EKVEYVIKCDMSALQ CCCEEEHHCCHHHHH | 17.71 | 25953088 | |
997 | Ubiquitination | EKVEYVIKCDMSALQ CCCEEEHHCCHHHHH | 17.71 | - | |
1008 | Phosphorylation | SALQRVLYRHMQAKG HHHHHHHHHHHHHCC | 8.80 | 23403867 | |
1014 | 2-Hydroxyisobutyrylation | LYRHMQAKGVLLTDG HHHHHHHCCEEECCC | 32.43 | - | |
1014 | Ubiquitination | LYRHMQAKGVLLTDG HHHHHHHCCEEECCC | 32.43 | - | |
1024 | Acetylation | LLTDGSEKDKKGKGG EECCCCCCCCCCCCC | 76.25 | 25953088 | |
1024 | Ubiquitination | LLTDGSEKDKKGKGG EECCCCCCCCCCCCC | 76.25 | - | |
1033 | Acetylation | KKGKGGTKTLMNTIM CCCCCCHHHHHHHHH | 42.83 | 19608861 | |
1050 | Phosphorylation | RKICNHPYMFQHIEE HHHCCCHHHHHHHHH | 11.74 | - | |
1081 | Ubiquitination | DLYRASGKFELLDRI HHHHHCCCHHHHHHH | 32.92 | 21890473 | |
1081 | Ubiquitination | DLYRASGKFELLDRI HHHHHCCCHHHHHHH | 32.92 | 21890473 | |
1081 | Ubiquitination | DLYRASGKFELLDRI HHHHHCCCHHHHHHH | 32.92 | 21890473 | |
1081 | Ubiquitination | DLYRASGKFELLDRI HHHHHCCCHHHHHHH | 32.92 | 21890473 | |
1081 | Ubiquitination | DLYRASGKFELLDRI HHHHHCCCHHHHHHH | 32.92 | 21890473 | |
1087 | Methylation | GKFELLDRILPKLRA CCHHHHHHHHHHHHH | 32.11 | - | |
1122 | Acetylation | YFAYRGFKYLRLDGT HHHHCCCCEEEECCC | 46.31 | 26051181 | |
1123 | Phosphorylation | FAYRGFKYLRLDGTT HHHCCCCEEEECCCC | 8.52 | 18083107 | |
1131 | Ubiquitination | LRLDGTTKAEDRGML EEECCCCCHHHHCEE | 50.01 | 21890473 | |
1213 | Ubiquitination | TVNSVEEKILAAAKY ECCCHHHHHHHHHHH | 29.52 | - | |
1219 | Acetylation | EKILAAAKYKLNVDQ HHHHHHHHHCCCCCH | 37.89 | 19822091 | |
1219 | Ubiquitination | EKILAAAKYKLNVDQ HHHHHHHHHCCCCCH | 37.89 | - | |
1220 | Phosphorylation | KILAAAKYKLNVDQK HHHHHHHHCCCCCHH | 18.91 | - | |
1221 | Ubiquitination | ILAAAKYKLNVDQKV HHHHHHHCCCCCHHH | 32.64 | - | |
1227 | Sumoylation | YKLNVDQKVIQAGMF HCCCCCHHHHHHCCC | 36.52 | - | |
1227 | Sumoylation | YKLNVDQKVIQAGMF HCCCCCHHHHHHCCC | 36.52 | - | |
1227 | Ubiquitination | YKLNVDQKVIQAGMF HCCCCCHHHHHHCCC | 36.52 | - | |
1237 | Ubiquitination | QAGMFDQKSSSHERR HHCCCCCCCCHHHHH | 54.90 | - | |
1238 | Phosphorylation | AGMFDQKSSSHERRA HCCCCCCCCHHHHHH | 31.29 | 21406692 | |
1239 | Phosphorylation | GMFDQKSSSHERRAF CCCCCCCCHHHHHHH | 42.63 | 21406692 | |
1240 | Phosphorylation | MFDQKSSSHERRAFL CCCCCCCHHHHHHHH | 36.14 | 21406692 | |
1291 | Sumoylation | DLEEPPLKEEDEVPD CCCCCCCCCCCCCCC | 65.90 | - | |
1345 | Phosphorylation | MEEDELPSWIIKDDA CCCCCCCCEEECCCH | 43.46 | 22199227 | |
1349 | Sumoylation | ELPSWIIKDDAEVER CCCCEEECCCHHCEE | 40.18 | - | |
1349 | Ubiquitination | ELPSWIIKDDAEVER CCCCEEECCCHHCEE | 40.18 | 21890473 | |
1353 (in isoform 3) | Ubiquitination | - | 52.48 | - | |
1358 | Phosphorylation | DAEVERLTCEEEEEK CHHCEECCCHHHHHH | 24.88 | 21130716 | |
1365 | Sumoylation | TCEEEEEKMFGRGSR CCHHHHHHHHCCCCC | 42.69 | 28112733 | |
1365 | Ubiquitination | TCEEEEEKMFGRGSR CCHHHHHHHHCCCCC | 42.69 | - | |
1366 | Sulfoxidation | CEEEEEKMFGRGSRH CHHHHHHHHCCCCCC | 4.94 | 21406390 | |
1371 | Phosphorylation | EKMFGRGSRHRKEVD HHHHCCCCCCCCCCC | 24.45 | 21406692 | |
1375 | Ubiquitination | GRGSRHRKEVDYSDS CCCCCCCCCCCCCCC | 56.83 | - | |
1379 | Phosphorylation | RHRKEVDYSDSLTEK CCCCCCCCCCCCCHH | 21.39 | 23927012 | |
1380 | Phosphorylation | HRKEVDYSDSLTEKQ CCCCCCCCCCCCHHH | 19.09 | 23401153 | |
1382 | Phosphorylation | KEVDYSDSLTEKQWL CCCCCCCCCCHHHHH | 31.11 | 29255136 | |
1384 | Phosphorylation | VDYSDSLTEKQWLKA CCCCCCCCHHHHHHH | 45.12 | 29255136 | |
1386 | Ubiquitination | YSDSLTEKQWLKAIE CCCCCCHHHHHHHHH | 41.35 | - | |
1396 | Phosphorylation | LKAIEEGTLEEIEEE HHHHHHCCHHHHHHH | 33.99 | 21712546 | |
1410 | Phosphorylation | EVRQKKSSRKRKRDS HHHHHHHHCCCCCCC | 51.18 | 29457462 | |
1417 | Phosphorylation | SRKRKRDSDAGSSTP HCCCCCCCCCCCCCC | 33.13 | 23401153 | |
1421 | Phosphorylation | KRDSDAGSSTPTTST CCCCCCCCCCCCCCC | 32.53 | 25159151 | |
1422 | Phosphorylation | RDSDAGSSTPTTSTR CCCCCCCCCCCCCCC | 37.17 | 29255136 | |
1423 | Phosphorylation | DSDAGSSTPTTSTRS CCCCCCCCCCCCCCC | 26.76 | 29255136 | |
1425 | Phosphorylation | DAGSSTPTTSTRSRD CCCCCCCCCCCCCCC | 33.20 | 28176443 | |
1426 | Phosphorylation | AGSSTPTTSTRSRDK CCCCCCCCCCCCCCC | 29.33 | 28176443 | |
1427 | Phosphorylation | GSSTPTTSTRSRDKD CCCCCCCCCCCCCCC | 25.05 | 28176443 | |
1428 | Phosphorylation | SSTPTTSTRSRDKDD CCCCCCCCCCCCCCC | 30.48 | 28176443 | |
1430 | Phosphorylation | TPTTSTRSRDKDDES CCCCCCCCCCCCCHH | 44.94 | 26074081 | |
1448 (in isoform 5) | Phosphorylation | - | 29.28 | - | |
1450 | Acetylation | RGRPPAEKLSPNPPN CCCCCHHHCCCCCCC | 57.27 | 23236377 | |
1451 (in isoform 3) | Phosphorylation | - | 8.50 | - | |
1452 | Phosphorylation | RPPAEKLSPNPPNLT CCCHHHCCCCCCCHH | 33.43 | 29255136 | |
1459 | Phosphorylation | SPNPPNLTKKMKKIV CCCCCCHHHHHHHHH | 34.95 | 23927012 | |
1464 | Acetylation | NLTKKMKKIVDAVIK CHHHHHHHHHHHHHH | 44.45 | 26051181 | |
1490 | Phosphorylation | EVFIQLPSRKELPEY EEEEECCCCCCCHHH | 65.66 | - | |
1492 | Ubiquitination | FIQLPSRKELPEYYE EEECCCCCCCHHHHH | 68.86 | - | |
1497 | Phosphorylation | SRKELPEYYELIRKP CCCCCHHHHHHHHCC | 10.57 | - | |
1519 | Phosphorylation | ERIRNHKYRSLNDLE HHHHHCCCCCHHHHH | 9.62 | 20873877 | |
1521 | Phosphorylation | IRNHKYRSLNDLEKD HHHCCCCCHHHHHHH | 28.56 | 20873877 | |
1570 | Phosphorylation | KIEKEDDSEGEESEE HHHHCCCCCCCCCHH | 60.88 | 20164059 | |
1575 | Phosphorylation | DDSEGEESEEEEEGE CCCCCCCCHHHHHCC | 46.11 | 20164059 | |
1586 | Phosphorylation | EEGEEEGSESESRSV HHCCCCCCCCCCCCE | 41.03 | 23927012 | |
1588 | Phosphorylation | GEEEGSESESRSVKV CCCCCCCCCCCCEEE | 42.44 | 23927012 | |
1590 | Phosphorylation | EEGSESESRSVKVKI CCCCCCCCCCEEEEE | 38.85 | 23927012 | |
1592 | Phosphorylation | GSESESRSVKVKIKL CCCCCCCCEEEEEEE | 35.25 | - | |
1617 | Phosphorylation | KGGRRRPSRGSRAKP CCCCCCCCCCCCCCC | 47.68 | 24144214 | |
1620 | Phosphorylation | RRRPSRGSRAKPVVS CCCCCCCCCCCCCCC | 28.14 | 24144214 | |
1627 | Phosphorylation | SRAKPVVSDDDSEEE CCCCCCCCCCCCHHH | 35.24 | 29255136 | |
1631 | Phosphorylation | PVVSDDDSEEEQEED CCCCCCCCHHHHHHH | 54.63 | 29255136 | |
1640 | Phosphorylation | EEQEEDRSGSGSEED HHHHHHCCCCCCCCC | 50.02 | 28355574 | |
1642 | Phosphorylation | QEEDRSGSGSEED-- HHHHCCCCCCCCC-- | 40.15 | 21955146 | |
1644 | Phosphorylation | EDRSGSGSEED---- HHCCCCCCCCC---- | 39.24 | 21955146 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
31 | S | Phosphorylation | Kinase | CK1D | P48730 | PSP |
35 | S | Phosphorylation | Kinase | CK1D | P48730 | PSP |
721 | S | Phosphorylation | Kinase | ATM | Q13315 | PSP |
- | K | Ubiquitination | E3 ubiquitin ligase | CHFR | Q96EP1 | PMID:22285184 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SMCA4_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SMCA4_HUMAN !! |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-188 AND LYS-455, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-609; SER-610; SER-613;SER-695; SER-699; SER-1382; SER-1452; SER-1570; SER-1575; SER-1627 ANDSER-1631, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-609; SER-610; SER-613;SER-1382 AND SER-1452, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-613; SER-1382; SER-1452;SER-1570; SER-1575; SER-1586; SER-1627; SER-1631; SER-1640; SER-1642AND SER-1644, AND MASS SPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-610 AND SER-721, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-11; SER-655; SER-657;SER-660; SER-662 AND SER-1452, AND MASS SPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-695 AND SER-1382, ANDMASS SPECTROMETRY. |